GSK598809 hydrochloride
CAS No. 863680-44-8
GSK598809 hydrochloride( GSK 598809 | GSK-598809 )
Catalog No. M16254 CAS No. 863680-44-8
GSK598809 hydrochloride is a potent, selective, CNS penetrant and orally bioavailable dopamine D3 receptor antagonist with pKi of 8.9; displays >100-fold selectivity over D2 and H1 receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK598809 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK598809 hydrochloride is a potent, selective, CNS penetrant and orally bioavailable dopamine D3 receptor antagonist with pKi of 8.9; displays >100-fold selectivity over D2 and H1 receptors.
-
DescriptionGSK598809 hydrochloride is a potent, selective, CNS penetrant and orally bioavailable dopamine D3 receptor antagonist with pKi of 8.9; displays >100-fold selectivity over D2 and H1 receptors; significantly attenuates the expression of conditioned place preference (CPP) to nicotine and cocaine; potentiates the hemodynamic effects of cocaine in dogs, also increases mean arterial blood pressure and heart rate in vivo.Other Indication Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsGSK 598809 | GSK-598809
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine Receptor
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number863680-44-8
-
Formula Weight517.972
-
Molecular FormulaC22H24ClF4N5OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name5-(5-((3-(1-(2-fluoro-4-(trifluoromethyl)phenyl)-3-azabicyclo[3.1.0]hexan-3-yl)propyl)thio)-4-methyl-4H-1,2,4-triazol-3-yl)-4-methyloxazole hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Micheli F, et al. J Med Chem. 2010 Jan 14;53(1):374-91.
2. Appel NM, et al. J Pharmacol Exp Ther. 2015 Sep;354(3):484-92.
3. Dodds CM, et al. Appetite. 2012 Aug;59(1):27-33.
4. Searle G, et al. Biol Psychiatry. 2010 Aug 15;68(4):392-9.
molnova catalog
related products
-
ML417
ML417 is a selective and brain penetrant agonist of D3 Dopamine (EC50 : 38 nM).Molecular modeling suggests that ML417 interacts with the D3R in a unique manner, possibly explaining its remarkable selectivity.?
-
SB-277011
A potent and selective dopamine D3 receptor antagonist with pKi of 8.0.
-
CCT241736
CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant mutants including FLT3-ITD and FLT3.
Cart
sales@molnova.com